Product Information
- 1H-Pyrrole-2-carboxamide, 4-[5-chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-, hydrochloride (1:1)
Ulixertinib is an investigational drug, which is an inhibitor of the receptor tyrosine kinase MET. Ulixertinib has been shown to inhibit the proliferation of cancer cells and induce tumor regression in a xenograft model of human lung adenocarcinoma. It also inhibits the growth of cancer cells by blocking cell cycle progression at G2/M phase and inducing apoptosis. Ulixertinib inhibits MET-mediated phosphorylation of downstream signaling molecules that regulate cell survival, proliferation, motility, angiogenesis, and metastasis. Ulixertinib hydrochloride is a high purity product with a purity level >98%.
Chemical properties
Technical inquiry about: 3D-GDD36610 Ulixertinib hydrochloride
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
